State Street’s Omega Protein OME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-509,374
| Closed | -$8.48M | – | 3770 |
|
|
2017
Q3 | $8.48M | Sell |
509,374
-20,954
| -4% | -$341K | ﹤0.01% | 2520 |
|
|
2017
Q2 | $9.49M | Buy |
530,328
+36,778
| +7% | +$687K | ﹤0.01% | 2419 |
|
|
2017
Q1 | $9.9M | Buy |
493,550
+58,588
| +13% | +$1.36M | ﹤0.01% | 2378 |
|
|
2016
Q4 | $10.9M | Buy |
434,962
+27,378
| +7% | +$647K | ﹤0.01% | 2292 |
|
|
2016
Q3 | $9.53M | Buy |
407,584
+33,366
| +9% | +$784K | ﹤0.01% | 2210 |
|
|
2016
Q2 | $7.48M | Sell |
374,218
-321
| -0.1% | -$5.99K | ﹤0.01% | 2377 |
|
|
2016
Q1 | $6.34M | Buy |
374,539
+32,054
| +9% | +$657K | ﹤0.01% | 2425 |
|
|
2015
Q4 | $7.61M | Buy |
342,485
+17,244
| +5% | +$359K | ﹤0.01% | 2338 |
|
|
2015
Q3 | $5.52M | Sell |
325,241
-11,350
| -3% | -$177K | ﹤0.01% | 2474 |
|
|
2015
Q2 | $4.63M | Sell |
336,591
-2,417
| -0.7% | -$32.1K | ﹤0.01% | 2660 |
|
|
2015
Q1 | $4.64M | Buy |
339,008
+7,305
| +2% | +$84.3K | ﹤0.01% | 2603 |
|
|
2014
Q4 | $3.51M | Buy |
331,703
+5,152
| +2% | +$61K | ﹤0.01% | 2759 |
|
|
2014
Q3 | $4.08M | Sell |
326,551
-4,050
| -1% | -$56.5K | ﹤0.01% | 2645 |
|
|
2014
Q2 | $4.52M | Buy |
330,601
+5,769
| +2% | +$75.4K | ﹤0.01% | 2650 |
|
|
2014
Q1 | $3.92M | Buy |
324,832
+5,248
| +2% | +$60.1K | ﹤0.01% | 2715 |
|
|
2013
Q4 | $3.93M | Buy |
319,584
+31,266
| +11% | +$367K | ﹤0.01% | 2714 |
|
|
2013
Q3 | $2.93M | Sell |
288,318
-24,509
| -8% | -$229K | ﹤0.01% | 2850 |
|
|
2013
Q2 | $2.81M | Buy |
+312,827
| New | +$3.15M | ﹤0.01% | 2786 |
|
State Street's OME Position: Q4 2017 in Review
State Street sold out of Omega Protein (OME) in Q4 2017, closing a stake of 509,374 shares — an estimated $8.48M sold.
State Street first reported a position in OME in Q2 2013 and held it in 18 quarters. The position peaked at $10.9M in Q4 2016. 0 funds tracked by Wall St. Rank hold OME as of Q4 2017.
- State Street reported no remaining Omega Protein position as of Q4 2017 after selling out during the quarter.
- State Street sold 509,374 Omega Protein shares in Q4 2017, an estimated $8.48M.
- State Street first reported a position in Omega Protein in Q2 2013 and held it in 18 quarters.
- State Street's Omega Protein position peaked at $10.9M in Q4 2016.
- 0 funds tracked by Wall St. Rank held Omega Protein as of Q4 2017.
Based on State Street's 13F filing for Q4 2017, filed 14 Feb 2018.